Promedius
PrivateLast Round
Series A
Extension
Mar 12, 2024
Total Funding Raised
$8.4M
Company Overview
Promedius is a healthtech company that provides an AI-powered platform using chest X-ray images to screen for osteoporosis and assist in diagnosis.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics, Computer Vision
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Promedius Comps
Public and private peers based on sector, stage, and business model.
Promedius Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 12, 2024 |
Key People
Founding team and executive leadership
Promedius Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Stassets Investment | Series A Extension |
| CRIT Ventures | Series A Extension |
| Korea Investment Partners | Series A Extension |
| Daol Investment | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Launched Osteo Signal, an AI for osteoporosis screening from chest X-rays.
- Jan 1, 2019
Founded in 2019 as a spin-off from Asan Medical Center.
Promedius Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Promedius's valuation, stock price, and market status.
